Skip to main content

Swing Trades (SGEN, AKAM)...

Seattle Genetics (SGEN) is biotech that has shown incredible growth over the last 3 years and is currently in a breakout pattern.

The trade:

     Long the stock at $50.71
     Long the September $42 Put at $1.65
     Stock to option ratio is 30:1
     The September put admittedly gives us scant leverage at just over 7x
     Breakeven prices on the trade are $56.21 on the upside (just over 3 ATRs to the upside) and $35.91 on the downside at expiration of the option

*I would be sure to size this trade accordingly because the option protection isn't great and there is a considerable amount of downside... that said, I like the stock and would definitely put on this trade.


Akamai Technologies (AKAM) is a cloud services technology company.  The sector has been hit hard of late (QCOM, WDC, RAX, etc...) and AKAM is showing signs of a long term downtrend after recently reverting back to its 50 day moving average.

The trade:

    Short the stock at $72.78
    Long the September $77.5 Call at $1.44
    Stock to option ration is -40:1
    The September call provides >14x leverage
    Breakeven prices on the trade are $69.18 (slightly more than 3 ATRs to the downside) and $83.05 on the upside at option expiration

Comments

Popular posts from this blog

Modeling Credit Risk...

     Here's a link to a presentation I gave back in August on modeling credit risk.  If anyone would like a copy of the slides, go ahead and drop me a line... https://www.gotostage.com/channel/39b3bd2dd467480a8200e7468c765143/recording/37684fe4e655449f9b473ec796241567/watch      Timeline of the presentation: Presentation Begins:                                                                0:58:00 Logistic Regression:                                     ...

Variable Types for Principal Component & Factor Modeling

TRANSFORMING RAW DATA INTO INSIGHT & ACTIONABLE INFORMATION After reading the book Moneyball for the first time, I built a factor model in hopes of finding a way to finally be competitive in my fantasy baseball league - which I had consistently been terrible at.  It worked immediately.  By taking raw data and turning it into actionable information, I was able to solve a problem that had long perplexed me.  It was like discovering a new power.  What else could I do with this? Today, I build models for everything and have come a long way since that first simple spreadsheet but still use a lot of the same concepts. To build a traditional factor model, you would regress a dependent variable against a series of independent variables and use the resulting beta coefficients as the factor weights... assuming your resulting r-squared and t-test showed a meaningful relationship of course. Variables typically fall into one of two categories... continuous or dichotomous....

Convexity as a Technical Indicator - Applications of the Second Derivative...

WHAT'S IN A NAME? In investment parlance, the term 'convexity' is typically reserved for the topic of fixed income risk; especially in regards to debt with embedded optionality where negative convexity is a prominent pricing factor.  However, it is important to recall that 'convexity' (or 'concavity', for that matter) is a mathematical measurement used to describe the second derivative of a continuous, nonlinear function on an interval. The issue with confining the term to a single connotation is that - for better or worse - investment tools have become increasingly nonlinear since the days of the 60/40 model and convexity is present in a number of applications.  The extent to which it has been circumscribed to a single asset class is evident in equity option jargon where the second derivative of the pricing function is called 'gamma' instead of convexity.  Of course, the argument could be made that the principle purpose of option vernacular is to c...